AAV-shRNA knockdown of Dkk3 improved obesity-associated muscle regeneration defect in mice, suggesting that it is a potential drug target for treating obesity-associated muscle weakness. The gene discussed is DKK3; the disease is obesity due to melanocortin 4 receptor deficiency.